Arylcyclopropylamine based demethylase inhibitors of LSD1 and their medical use
US9708309B2 · kind B2 · utility
6Cited by
27References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 9, 2015 |
| Grant date | Jul 18, 2017 |
| Priority date | — |
| Expiry date | Sep 9, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to (hetero)aryl cyclopropylamine compounds, including particularly the compounds of formula (I) as described and defined herein, and their use in therapy, including, e.g., in the treatment or prevention of cancer, a neurological disease or condition, or a viral infection. Thus, in one specific aspect the invention relates to formulas (II), (III), (IV), (V), (VI), (VII), (VIII), (IX).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.